Benserazide hydrochloride, 98%, peripherally acting DOPA decarboxylase inhibitor

Name: Benserazide hydrochloride, 98%, peripherally acting DOPA decarboxylase inhibitor | 14919-77-8
Brand: J&K Chemical
SKU: JK266243_5_G
Price: 338.0 USD
Availability: OutOfStock

Cat. No JK266243_5_G

Vendor: J&K Chemical

Product Information

Product Name

Benserazide hydrochloride, 98%, peripherally acting DOPA decarboxylase inhibitor

Brand Name

J&K

Product Number

266243

CAS

14919-77-8

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

26964

IUPAC Name

2-amino-3-hydroxy-N'-(2,3,4-trihydroxyphenyl)methylpropanehydrazide;hydrochloride

InChI Key

ULFCBIUXQQYDEI-UHFFFAOYSA-N

SMILES

C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

A spatiotemporal hypergraph self-attention neural networks framework for the identification and pharmacological efficacy assessment of Parkinson’s disease motor symptoms

Publication Name: npj Parkinson's Disease

Publication Date: 2025-11-26

DOI: 10.1038/s41531-025-01187-6

Subsecond dopamine fluctuations do not specify the vigor of ongoing actions

Publication Name: Nature Neuroscience

Publication Date: 2025-11-10

DOI: 10.1038/s41593-025-02102-1

Safety of COMT-inhibitors in parkinson’s disease: a phase-IV comparative study on adverse events of Tolcapone, Entacapone and Opicapone

Publication Name: Journal of neural transmission (Vienna, Austria : 1996)

Publication Date: 2025-11-01

DOI: 10.1007/s00702-025-03053-4

Sinomenine Modifies Parkinson’s Disease Through Nrf2 Activation

Publication Name: Neurochemical Research

Publication Date: 2025-09-18

DOI: 10.1007/s11064-025-04557-x

Saikosaponin A, a bioactive compound from Bupleuri radix, protects dopaminergic neurons and correlates with NURR1 expression in 6-hydroxydopamine-injected hemi-Parkinsonian mouse model

Publication Name: Pharmacological reports : PR

Publication Date: 2025-08-14

DOI: 10.1007/s43440-025-00772-z

Benserazide hydrochloride, 98%, peripherally acting DOPA decarboxylase inhibitor

Product Information

General Information

Safety Information

References Data Source From Pubchem

A spatiotemporal hypergraph self-attention neural networks framework for the identification and pharmacological efficacy assessment of Parkinson’s disease motor symptoms

Subsecond dopamine fluctuations do not specify the vigor of ongoing actions

Safety of COMT-inhibitors in parkinson’s disease: a phase-IV comparative study on adverse events of Tolcapone, Entacapone and Opicapone

Sinomenine Modifies Parkinson’s Disease Through Nrf2 Activation

Saikosaponin A, a bioactive compound from Bupleuri radix, protects dopaminergic neurons and correlates with NURR1 expression in 6-hydroxydopamine-injected hemi-Parkinsonian mouse model